2,078 results on '"Gandaglia G"'
Search Results
52. Improving prediction of local stage by PSMA-PET: Development of a novel integrated tool for extracapsular extension and seminal vesicle invasion combining clinical and imaging features in localized prostate cancer
53. Is there an impact of the center performing baseline multiparametric MRI on active surveillance outcomes in prostate cancer patients?
54. Tailoring the optimal use of androgen-deprivation therapy concomitant to post-operative radiotherapy among men with pN1 prostate cancer. Long-term results of a large, single Institution series
55. Impact of neoadjuvant immune-checkpoint inhibitor on intra and post operative outcomes in patients with muscle-invasive bladder cancer treated with radical cystectomy
56. Can we predict the site of positive surgical margins based on the site of the index lesion at multiparametric mri? A topographic, single center study
57. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
58. PE086 - Orthotopic neobladder reconstruction following robot-assisted radical cystectomy: Systematic review of clinical outcomes and step-by-step description
59. Does metastases-direct therapy guided by PSMA PET/CT really improve oncologic outcomes in oligorecurrent prostate cancer patients?
60. The impact of PSMA PET/CT on oncologic outcomes of patients with recurrent prostate cancer: The experience of 3 high-volume European centers
61. Unilateral pelvic lymph node dissection in prostate cancer patients diagnosed in the era of MRI-targeted biopsy: A study that challenges the dogma
62. Contemporary 90-day mortality rates after radical cystectomy in the elderly
63. The effect of age at diagnosis on prostate cancer mortality: A grade-for-grade and stage-for-stage analysis
64. Re: "Timing of radiotherapy (RT) after radical prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047]", by C. C. Parker et al. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4.
65. Added value of mpmri in the stratification of patients with high-risk patients prostate cancer treated with radical prostatectomy: implications for tailored multi-modal strategies
66. Who is the right patient for salvage radical prostatectomy? oncological outcomes compared between EAU guidelines-compliant and non-compliant patients
67. Does a positive multi-parametric MRI always warrant prostate biopsy? the importance of integrating clinical and imaging data based on a large, multi-institutional series
68. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: the key role of PSA kinetics
69. Topographic description of the site of positive MPMRI and impact on the risk of positive surgical margins at robot-assisted nerve sparing radical prostatectomy. implications for accurate surgical approaches
70. Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series
71. How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: a novel risk stratification tool
72. 99M-technetium-psma radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection: a phase 2 prospective, single-institution study
73. The risk of recurrence in cN1 prostate cancer patients treated with radical prostatectomy varies according to the type preoperative staging. a comparison between 68ga-PSMA-PET versus conventional imaging in a large, multi-institutional study
74. A more extended pelvic lymph node dissection decreases recurrence rates in selected prostate cancer patients undergoing radical prostatectomy
75. The key role of concomitant androgen-deprivation therapy on the efficacy of imaging guided treatments in men with biochemical recurrent prostate cancer after radical prostatectomy and positive 68Ga-PSMA PET/CT scan
76. Oncologic surveillance for variant histology upper tract urothelial carcinoma
77. Toxicity profile of immediate post-prostatectomy radiation therapy: results from a large multi-institutional series
78. The impact of PSMA PET/CT on oncologic outcomes of patients with recurrent prostate cancer: the experience of 3 high-volume european centers
79. Are extended pelvic lymph node dissection-related complications still an issue in contemporary patients treated with robot-assisted radical prostatectomy? a prospective assessment using a standardized collection system
80. The impact of variant histology on the probability of lymph node involvement at imaging: CT scan vs FDG PET
81. When is neoadjuvant androgen deprivation therapy beneficial for highly aggressive prostate cancer before radical prostatectomy? implications for multi-modal tailored approaches and trials design
82. Impact of 68Ga-PSMA PET/CT and metastasis-directed therapy on clinical recurrence in patients with biochemical recurrence after radical prostatectomy. results from a single center series
83. Can low risk disease outside the index lesion be left untreated in men suitable for focal therapy? development of novel criteria to identify potential candidates for focal therapy among patients with intermediate risk prostate cancer and positive multi-parametric MRI
84. When can we de-intensify treatments in isup grade group 5 prostate cancer? long-term results of a single center, high volume series
85. The prognostic value of the number of positive targeted cores in men with positive multiparametric magnetic resonance imaging of the prostate. results from a large, multi-institutional series
86. Optimizing timing and indications for 68Ga-PSMA PET/CT in patients with biochemical recurrent prostate cancer after radical prostatectomy
87. Definition and predictors of upgrading at final pathology in prostate cancer patients undergoing MRI-targeted and systematic biopsies: results from a large, multi-institutional series
88. Prostate cancers detected at multi-parametric MRI targeted versus systematic biopsies: are they equal? Results from a large multi-institutional series
89. The role of FDG PET in the staging of bladder cancer patients candidate for radical cystectomy
90. Implementing the follow-up schedule after radical nephrouretrectomy for low risk upper tract urothelial carcinoma
91. The impact of frailty status on surgical outcomes after robot-assisted radical prostatectomy - a prospective assessment using a standardized collection system for perioperative outcomes
92. Has the introduction of mpMRI in the diagnostic pathway of prostate cancer led to improved oncological outcomes after radical prostatectomy? Result from a large single-institutional series
93. Increased awareness of surgical outcomes improves long-term functional outcomes after robot-assisted radical prostatectomy. A prospective assessment following implementation of prospective data collection
94. Does centralized revision of prostate biopsy impact on active surveillance outcomes? results from a single, high-volume institution series
95. The impact of histological variants on the performance characteristics of 68Ga-PSMA PET/CT in the primary and recurrent setting
96. Drop-out rates from active surveillance for disease progression remain consistent and not negligible over time. A plea for long-term assessment based on a large, prospectively collected active surveillance cohort
97. Assessing the role of frailty status on oncologic and functional outcomes in patients treated with robot-assisted radical prostatectomy for localized prostate cancer
98. Acute kidney injury and its duration in patients treated with radical cystectomy in the enhanced recovery after surgery era: optimizing the selection of patients for restrictive fluid therapy
99. 99m-Technetium-PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing with radical prostatectomy and extended pelvic lymph node dissection
100. Comparative analyses of micro-ultrasound versus MRI-targeted biopsy for the diagnosis of clinically significant prostate cancer. Preliminary results from the prospective us-mirror trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.